Stephen Doktycz
Vantage Specialties, Inc., wholly owned subsidiary of Vantage Specialty Chemicals, Inc., a provider of naturally derived ingredients, names Stephen Doktycz as its chief executive officer. Doktycz, who has been serving as interim ceo since October 2019, will also sit on the company’s board of directors and is an equity investor alongside H.I.G. Capital, LLC in the company.
Before joining Vantage, Doktycz spent more than 27 years with The Dow Chemical Company in several senior leadership positions, including corporate director, responsible for spearheading the definition, separation, stand-up and sale of Dow’s chlorine-related businesses, and global director, corporate and strategic development. In his globally focused roles in strategic planning, finance, mergers and acquisitions and corporate development, he reportedly led initiatives to improve Dow’s business portfolio, deliver long-term business viability, develop emerging markets and form joint ventures.
Most recently, Doktycz was a senior advisor to H.I.G. supporting acquisitions, divestitures and portfolio company performance improvement. Doktycz came to H.I.G. from LyondellBasell, a plastics, chemicals and refining company based in Houston where he held the position of senior vice president, strategic planning and transactions. At LyondellBasell, Doktycz’s responsibilities included defining the corporate vision and strategy and driving inorganic growth, which resulted in multiple investments by the company moving LyondellBasell into sustainable polymer offerings and polymer derivatives.
Doktycz has a Ph.D. in chemistry from the University of Illinois at Urbana-Champaign, an MBA from Northwestern University and a B.A. in chemistry from the University of Illinois at Chicago.
For more information, visit: www.vantagegrp.com
